Clinical trial
Multi-center Study in the Frequency of HPA Antibodies and the Distribution of Antigen and Antibodies in Chinese Blood Disease Patients
NCT03408158 is registered in ClinicalTrials.gov with Guangzhou First People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multi-center Study in the Frequency of HPA Antibodies and the Distribution of Antigen and Antibodies in Chinese Blood Disease Patients
- Lead sponsor
- Guangzhou First People's Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 1, 2017
- Completion date
- December 31, 2020
- Enrollment
- 6,170 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
antibody-mediated rejection, blood disease, platelet refractoriness